Techgrapher – Setup Your Online IP Centre Today
  • Home
  • Articles
    • Agriculture
      • Plant Varieties
      • Seeds
    • Biotechnology
      • Biologics
      • Pharmaceuticals
      • Food
      • Microbiology
      • Bio-medical Engineering
      • Traditional Knowledge Bio-technology
    • Electrical & Electronics
      • Electricity
      • Communication
    • Chemical
      • Agrochemicals
      • Pharmaceuticals
      • Polymers
      • Metallurgy
      • Traditional Knowledge Chemical
      • Medical Science
      • Veterinary Science
      • Organic Chemistry
      • Inorganic Chemistry
      • Treatment of Water
      • Petroleum
      • Bio-chemistry
      • Mining
      • Combinatorial Technology
      • Textiles
      • Paper
      • Nanotechnology
    • Mechanical
      • General Engineering
      • Physics
      • Agriculture Engineering
      • Traditional Knowledge Mechanical
      • Automotive
      • Engines
      • Lighting
      • Heating
      • Weapons
      • Instruments
      • Pumps
      • Blasting
      • Microstructural Technology
    • Civil
      • Hydraulic Engineering
      • Building
      • Earth Drilling
      • Infrastructure
    • Computer Science
      • Artificial Intelligence
      • Big Data
      • Machine Learning
      • Cryptocurrency
      • Blockchain
    • Physics
      • Instruments
      • Nucleonics
    • IP Centre
  • Pricing
  • ConsultHot
  • Login
  • My Account
    • Edit Profile
  •  Log In Sign Up
Techgrapher – Setup Your Online IP Centre Today
  • Home
  • Articles
    • Agriculture
      • Plant Varieties
      • Seeds
    • Biotechnology
      • Biologics
      • Pharmaceuticals
      • Food
      • Microbiology
      • Bio-medical Engineering
      • Traditional Knowledge Bio-technology
    • Electrical & Electronics
      • Electricity
      • Communication
    • Chemical
      • Agrochemicals
      • Pharmaceuticals
      • Polymers
      • Metallurgy
      • Traditional Knowledge Chemical
      • Medical Science
      • Veterinary Science
      • Organic Chemistry
      • Inorganic Chemistry
      • Treatment of Water
      • Petroleum
      • Bio-chemistry
      • Mining
      • Combinatorial Technology
      • Textiles
      • Paper
      • Nanotechnology
    • Mechanical
      • General Engineering
      • Physics
      • Agriculture Engineering
      • Traditional Knowledge Mechanical
      • Automotive
      • Engines
      • Lighting
      • Heating
      • Weapons
      • Instruments
      • Pumps
      • Blasting
      • Microstructural Technology
    • Civil
      • Hydraulic Engineering
      • Building
      • Earth Drilling
      • Infrastructure
    • Computer Science
      • Artificial Intelligence
      • Big Data
      • Machine Learning
      • Cryptocurrency
      • Blockchain
    • Physics
      • Instruments
      • Nucleonics
    • IP Centre
  • Pricing
  • ConsultHot
  • Login
  • My Account
    • Edit Profile
  •  Log In Sign Up
0
  • Bio-chemistry
  • Chemical

Impurity Matters

  • February 4, 2020
  • No comments
  • 555 views
  • 2 minute read
  • Dr. Venkata Subramanian Raman
Total
12
Shares
0
12
0
0
0
Total
12
Shares
Share 0
Share 12
Tweet 0
Share 0
Share 0

Impurity matters

Abstract:

Vosaroxin, SNS-595 or AG-7352 or voreloxin, is a topoisomerase II inhibitor with anti-tumor activity.1 The Patent application, 1992/CHENP/2012, was granted and covers a process for preparing substantially pure SNS-595 by controlling the amount of impurities, which affects purity and solubility.

Background:

The application, 1992/CHENP/2012, which is titled “Process for Preparation of a SNS-595 substance” covers a process for preparing nearly pure SNS-595. This application entered India as a National phase application, from an International application, PCT/US2010/047776, and takes priority from a US application, US 61/240,161.2 Every patent application targets an unsolved problem in a particular domain, and this application covers synthesizing substantially pure SNS-595, see Scheme 1, with negligible fractions of other by-products, which was an unsolved problem in this domain. The initially filed claims covered for a process involving synthesis of substantially pure SNS-595 from Compound 3 (Claims 1 to 4), a separate process claims involving synthesis of compound 3 (claims 5 and 6), process covering the synthesis of SNS-595 from compound 1 (Claims 7 and 10), and composition covering SNS-595 (Claims 11 to 32), see scheme 1.

Analysis:

The Controller issued FER, which carried objections under  non-patentable inventions, Section 3(d), Section 3(e), and inventive step (Section 2(1)(ja)).3 In the reply to FER, the Applicant deleted all the process related claims to overcome Section 3(d), which was already disclosed in WO 2007/146335 A2. Further, the Applicant argued that contrary to the prior art, the composition claims recognized the presence of impurities and its effect on solubility.4 The amended claims included composition and a method of obtaining the composition comprising SNS-595 as stated above. In regard to Section 3(e) objection, the Applicant pursued that the composition was a synergistic mixture, which affected purity and solubility of the composition, which was absent in the prior art composition. However, the Controller retained the inventive step objection in the hearing notice, stating “It would have been obvious to one of ordinary skill in the art at the time of the invention to have known that dehydrated SNS-595 with NaOH followed by neutralization and washing with water and ethanol to purify said product as taught by D1 and repeated the purification process in order to obtain a more pure product. It is well within the purview of the skilled artisan to know that multiple rounds of purification are typically necessary in order to obtain optimum purity. D1”.  The propensity of a compound to form particles in aqueous solution depends on its solubility and the presence of other components in the solution. The applicant, in their supporting documents, argued that improved purification steps affected the number of particles formed in the aqueous solution and influenced solubility, which was outside the purview of ordinarily skilled in the art. And the data also showed less than 1000 particles with greater than 10 ߂ compared to the prior art, which would have a significant impact on purity and solubility of SNS-595. This application was eventually granted.

REFERENCES:

  1. https://en.wikipedia.org/wiki/Vosaroxin
  2. https://ipindiaservices.gov.in/publicsearch
  3. http://ipindia.nic.in/writereaddata/Portal/ev/sections/ps2.html; http://ipindia.nic.in/writereaddata/Portal/ev/sections/ps3.html
  4. https://patents.google.com/patent/US20110086876?oq=WO+2007%2f146335+A2
Total
12
Shares
Share 0
Share 12
Tweet 0
Share 0
Share 0
Dr. Venkata Subramanian Raman

Dr. Venkat specializes in Chemical, Pharmaceutical and Life Sciences, who received his Master's degree in Chemistry from IIT Madras and earned Ph.D in Chemistry from Tufts University. He is a registered Patent Agent (IN/PA 3924). Prior to joining Techgrapher, he worked as a Patent Analyst, analyzed Patent Applications for USPTO, at CPA Global (Michigan) and learned commercializing research products during his tenure at Technology Transfer Office in Tufts University, Boston.

Related Topics
  • Chemistry
You May Also Like
How Indian Patent Office Rejected Patent Applications on Artificial Sweeteners
View Post
  • Chemical
  • Pharmaceuticals

How the Indian Patent Office Rejected Applications on Artificial Sweeteners

  • June 9, 2019
  • Dr. Archana Thakur
View Post
  • Chemical
  • Pharmaceuticals

Patent Study on Stevia Sweeteners: An Indian Perspective

  • May 10, 2019
  • Dr. Archana Thakur
Negative Limitations in Pharmaceutical Patents
View Post
  • Chemical
  • Pharmaceuticals

Introducing Negative Limitations in Pharmaceutical Patents

  • April 21, 2019
  • Dr. Venkata Subramanian Raman
Numerical Ranges in Pharmaceutical Patents
View Post
  • Chemical
  • Pharmaceuticals

Numerical Ranges in Pharmaceutical Patents

  • April 20, 2019
  • Dr. Venkata Subramanian Raman
Understanding Pharmaceutical Patents
View Post
  • Chemical
  • Pharmaceuticals

Understanding Pharmaceutical Patents

  • April 20, 2019
  • Dr. Venkata Subramanian Raman

Leave a Reply Cancel reply

You must be logged in to post a comment.

Techgrapher – Setup Your Online IP Centre Today
  • About
  • Terms of Service
  • Privacy Policy
  • Contact Us
  •  Log In Sign Up
Do Intellectual Property Right

Input your search keywords and press Enter.